NASDAQ: BOLTBolt Biotherapeutics Inc Stock Ownership - Who owns Bolt Biotherapeutics?
Insider buying vs selling
Have Bolt Biotherapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Sarah Nemec | Senior VP Finance and PAO | 2024-12-16 | 2,500 | $0.50 | $1.24kBuy |
| William P. Quinn | President CEO and CFO | 2024-12-16 | 2,500 | $0.50 | $1.24kBuy |
BOLT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BOLT insiders and whales buy or sell their stock.
BOLT Shareholders
What type of owners hold Bolt Biotherapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vivo Capital VIII LLC | 306.64% | 5,885,846 | $29.84M | Insider |
| Holdings A. Novo | 192.97% | 3,703,991 | $18.78M | Insider |
| Edgar Engleman | 171.58% | 3,293,286 | $16.70M | Insider |
| James Healy | 143.50% | 2,754,437 | $13.96M | Insider |
| Sofinnova Venture Partners X LP | 143.50% | 2,754,437 | $13.96M | Insider |
| Mahendra Shah | 75.45% | 1,448,286 | $7.34M | Insider |
| Vivo Capital LLC | 9.17% | 176,064 | $892.64k | Institution |
| Tang Capital Management LLC | 8.69% | 166,879 | $846.08k | Institution |
| Sofinnova Investments Inc | 7.18% | 137,721 | $698.25k | Institution |
| Pivotal Bioventure Partners Investment Advisor LLC | 4.93% | 94,573 | $479.49k | Institution |
BOLT vs Biotech Stocks
Bolt Biotherapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.